Oncopharmpod
Afamitresgene Autoleucel & Vorasidenib
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:29
- More information
Informações:
Synopsis
A new cellular therapy is approved for synovial sarcoma and the anticipated approval has occurred for the dual IDH1/IDH2 inhibitor, vorasidenib.
